George M. Jenkins

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
2 years
Director since
2024

2 years of board service in total across 1 board, counting each seat separately. Longest: Palvella Therapeutics Inc., 1 year.

1 year · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 15, 2026 Palvella Therapeutics Inc. Open-market sale −954 $149.38 $142,509
Sep 15, 2026 Palvella Therapeutics Inc. Open-market sale −263 $150.40 $39,555
Sep 15, 2026 Palvella Therapeutics Inc. Open-market sale −560 $151.33 $84,745
Sep 14, 2026 Palvella Therapeutics Inc. Open-market sale −5,632 $151.46 $853,023
Sep 14, 2026 Palvella Therapeutics Inc. Open-market sale −6,160 $152.12 $937,059
Sep 14, 2026 Palvella Therapeutics Inc. Open-market sale −1,560 $153.10 $238,836
Sep 11, 2026 Palvella Therapeutics Inc. Open-market sale −6,520 $150.62 $982,042
Sep 11, 2026 Palvella Therapeutics Inc. Open-market sale −4,577 $151.72 $694,422
Sep 11, 2026 Palvella Therapeutics Inc. Open-market sale −1,274 $153.06 $194,998
Mar 30, 2026 Palvella Therapeutics Inc. Open-market purchase +445 $112.30 $49,974
Feb 27, 2026 Palvella Therapeutics Inc. Open-market purchase +4,000 $125.00 $500,000
Apr 9, 2025 Palvella Therapeutics Inc. Open-market purchase +2,500 $20.13 $50,325
Apr 9, 2025 Palvella Therapeutics Inc. Open-market purchase +2,490 $20.27 $50,472
Dec 18, 2024 Palvella Therapeutics Inc. Open-market purchase +4,000 $12.93 $51,720

Questions about George M. Jenkins

What boards is George M. Jenkins on?

George M. Jenkins sits on the board of Palvella Therapeutics Inc.

How long has George M. Jenkins served on boards?

Our records show at least 2 years of board service across 1 board, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.